Visit Bulgaria
Visit Bulgaria
... from the studies will be presented at an upcoming scrutiny conference in Europe, causing Amgen shares to uprise 5-cents to $59.89 in after-hours trading.
and more »
Tuesday, August 18, 2009
Amgen's Vectibix Meets Goal In Colon Cancer Study - Visit Bulgaria
Visit Bulgaria
Visit Bulgaria
... from the studies will be presented at an upcoming scrutiny conference in Europe, causing Amgen shares to uprise 5-cents to $59.89 in after-hours trading.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment